Literature DB >> 15363512

1,3,3-Trinitroazetidine (TNAZ), a melt-cast explosive: synthesis, characterization and thermal behaviour.

N Sikder1, A K Sikder, N R Bulakh, B R Gandhe.   

Abstract

1,3,3-Trinitroazetidine (TNAZ) has been prepared at a laboratory scale in HEMRL. The structure of the compound has been confirmed by IR, NMR, mass, elemental analysis and by X-ray crystallography. HPLC technique has been employed to confirm the purity of TNAZ (>99%). The compound is further characterized by thermal techniques and is found to undergo limited decomposition at its melting point. Small scale sensitivity tests have also been carried out and the results show that TNAZ is significantly more sensitive to mechanical stimuli than TNT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363512     DOI: 10.1016/j.jhazmat.2004.06.002

Source DB:  PubMed          Journal:  J Hazard Mater        ISSN: 0304-3894            Impact factor:   10.588


  6 in total

Review 1.  The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

Authors:  Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2018-02-14       Impact factor: 5.858

Review 2.  The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications.

Authors:  Kearsley M Dillon; Ryan J Carrazzone; John B Matson; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-03-26       Impact factor: 5.858

3.  A comparative study of the structures, thermal stabilities and energetic performances of two energetic regioisomers: 3(4)-(4-aminofurazan-3-yl)-4(3)-(4-nitrofurazan-3-yl)furoxan.

Authors:  Jiarong Zhang; Fuqiang Bi; Lianjie Zhai; Huan Huo; Zhi Yang; Bozhou Wang
Journal:  RSC Adv       Date:  2020-08-27       Impact factor: 4.036

4.  A promising TNT alternative 3,3'-bi(1,2,4-oxadiazole)-5,5'-diylbis(methylene)dinitrate (BOM): thermal behaviors and eutectic characteristics.

Authors:  Xiong Yang; Jing Zhou; Xiaoling Xing; Yafeng Huang; Zhengfeng Yan; Qi Xue; Xiaofeng Wang; Bozhou Wang
Journal:  RSC Adv       Date:  2020-07-14       Impact factor: 4.036

5.  RRx-001 Exerts Neuroprotection Against LPS-Induced Microglia Activation and Neuroinflammation Through Disturbing the TLR4 Pathway.

Authors:  Jie Fang; Jing She; Fang Lin; Jun-Chao Wu; Rong Han; Rui Sheng; Guanghui Wang; Zheng-Hong Qin
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 6.  RRx-001, A novel dinitroazetidine radiosensitizer.

Authors:  Bryan Oronsky; Jan Scicinski; Shoucheng Ning; Donna Peehl; Arnold Oronsky; Pedro Cabrales; Mark Bednarski; Susan Knox
Journal:  Invest New Drugs       Date:  2016-02-03       Impact factor: 3.850

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.